Key result
Prolonged antibiotics and hydroxychloroquine are linked to clinical improvement in Baggio-Yoshinari Syndrome.
Why the study?
Baggio–Yoshinari syndrome differs from classic Lyme disease in transmission, clinical evolution, and autoimmune manifestations in Brazil, requiring clinical characterization.
Case Report (n=5)
Yes
Baggio-Yoshinari syndrome should be considered in the differential diagnosis for patients bitten by ticks in Brazil presenting with erythema migrans and/or headache.
Compared to classic Lyme disease (LD), Baggio–Yoshinari syndrome (BYS) has the following distinctive characteristics: it is transmitted in the Amazon area and Northeast, Central-West, Southeast, and South regions of Brazil by hard ticks, notably Amblyomma cajannense or Rhipicefalus sp. The absence of Ixodes sp. ticks in areas at risk of BYS in Brazil is probably the main reason for the disease’s differences from LD in the United States, Europe, and Asia. Biodiversity and climate probably favor the formation of atypical pleomorphic Borrelias, which have not yet been cultivated or isolated. Clinically, the first manifestation of BYS is the erythema migrans as in the classic forms of Lyme disease, but BYS is distinguished from LD by its prolonged clinical evolution, with a high frequency of relapses and the appearance of autoimmune manifestations. Prevalent symptoms are headache and erythema nodosum. Five clinical cases of BYS in patients who contracted the disease in the Brazilian Amazon rainforest are described here. This syndrome should be considered among differential diagnoses in patients bitten by ticks in Brazil who present with erythema migrans and/or headache. It is important to pursue an early diagnosis because symptoms respond well to antibiotics in the early stages; if treatment is started late, a chronic course with articular and neurological sequelae can be detected.
No takes yet. Share an insight, caveat, or question.
Bonoldi et al. (2024) conducted a case report in Baggio-Yoshinari Syndrome (n=5). Prolonged antibiotic and hydroxychloroquine therapy (Yoshinari protocol) was evaluated. Five patients with Baggio-Yoshinari Syndrome contracted in the Brazilian Amazon rainforest showed clinical improvement of erythema migrans, neurological, and articular symptoms following prolonged treatment with antibiotics and hydroxychloroquine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: